MDL’s Research and Development Department is divided into two broad-based major divisions, aptly named ‘Research’ and ‘Development’.

The Research Division is comprised of the following subdivisions: Molecular & Cellular Biology, Antimicrobial Resistance, Pharmacogenomics, and Virology. Within each, we have established multiple Centers of Excellence with common priorities consistently applied to their individual research projects—the publication of scientific information in peer-reviewed research journals, the presentation of this work at national and international scientific symposia, the pursuit of novel intellectual property, and the acquisition of outside governmental and commercial research support to aid in continued expansion.

The Development Division is comprised of the following subdivisions: Obstetrics / Gynecology / Urinary Tract Infections, Blood-Borne Pathogens, Respiratory Infectious Diseases, Cytogenetics, and Antigen Discovery. The priorities of this group are the conception, development and rigorous validation of state-of-the-art clinical diagnostic assays for use in our CLIA-certified laboratory and also for licensing to other manufacturing companies to be incorporated in FDA-approved serological diagnostic assays. Innovation in the collection of biological specimens and transport to the laboratory for downstream testing is also actively sought through ongoing collaborations with physicians and hospitals.